On Dec 07, major Wall Street analysts update their ratings for $Patterson (PDCO.US)$, with price targets ranging from $23 to $29.
BofA Securities analyst Allen Lutz maintains with a buy rating, and maintains the target price at $29.
Evercore analyst Elizabeth Anderson CFA maintains with a hold rating, and adjusts the target price from $22 to $23.
Baird analyst Jeff Johnson maintains with a hold rating, and adjusts the target price from $28 to $25.
Piper Sandler analyst Jason Bednar maintains with a hold rating, and adjusts the target price from $26 to $24.
Furthermore, according to the comprehensive report, the opinions of $Patterson (PDCO.US)$'s main analysts recently are as follows:
The firm noted that following another EPS miss and guidance reduction, it appears that the company's understanding of their own operations and market conditions, particularly in the dental segment, has not improved as management had earlier expected.
Patterson Companies' Q2 results were described as 'weak' due to challenges in lukewarm end markets along with specific company issues. Although expectations for lowered FY25 earnings predictions were previously present, achieving revised targets remains formidable, as approximately 70% of FY25 EPS is expected to come from the latter half, contrasting with the last three-year average of 59%.
Here are the latest investment ratings and price targets for $Patterson (PDCO.US)$ from 4 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
美東時間12月7日，多家華爾街大行更新了$帕特森 (PDCO.US)$的評級，目標價介於23美元至29美元。
美銀證券分析師Allen Lutz維持買入評級，維持目標價29美元。
Evercore分析師Elizabeth Anderson CFA維持持有評級，並將目標價從22美元上調至23美元。
貝雅分析師Jeff Johnson維持持有評級，並將目標價從28美元下調至25美元。
派傑投資分析師Jason Bednar維持持有評級，並將目標價從26美元下調至24美元。
此外，綜合報道，$帕特森 (PDCO.US)$近期主要分析師觀點如下：
該公司注意到，在經歷了另一次每股收益不達標和降低指引後，似乎公司對自身運營和市場狀況的理解，特別是在牙科領域，並沒有如管理層早期所預期的那樣改善。
帕特森公司的第二季度業績被形容爲「疲軟」，原因是溫和的終端市場以及公司特定問題的挑戰。儘管早前對降低2025財年的盈利預測已有預期，但實現修訂後的目標仍然具有挑戰性，因爲預計約70%的2025財年每股收益將來自下半年的業績，而這一比例與過去三年的平均水平相比爲59%。
以下爲今日4位分析師對$帕特森 (PDCO.US)$的最新投資評級及目標價：
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
